Skip to content

Wednesday, October 28, 2026

Data from SEC filings, checked daily

Public filings, plainly told

About Method Sources Newsletter

Insider tradingForm 4

TAKEDA PHARMACEUTICAL CO LTD (TAK) Insider Trading

4 open-market trades reported since Aug 19, 2026: 0 purchases worth $0 and 4 sales worth $3.39M.

By insider

Insider	Role	Buys	Bought	Sells	Sold	Latest
Lauren Rusckowski Duprey	Chief Transformation Officer	0	$0	1	$640K	Sep 15, 2026
Andrew Stewart Plump	President	0	$0	2	$2.51M	Sep 3, 2026
Nicola Deidre Petal Greenway	Chief Human Resources Officer	0	$0	1	$235K	Aug 19, 2026

All trades

TAK insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	3 mo. after	Filing
Sep 15	Sep 14	Lauren Rusckowski DupreyChief Transformation Officer	Chief Transformation Officer	▼ SELL	34,535	18.54	$640K	−15%		Form 4 ↗
Sep 3	Sep 2	Andrew Stewart PlumpPresident	President (ind.)	▼ SELL10b5-1	116,191	18.49	$2.15M	−44%		Form 4 ↗
Aug 21	Aug 19	Andrew Stewart PlumpPresident	President (ind.)	▼ SELL10b5-1	19,651	18.49	$363K	−7.0%		Form 4 ↗
Aug 19	Aug 18	Nicola Deidre Petal GreenwayChief Human Resources Officer	Chief Human Resources Officer	▼ SELL	12,980	18.11	$235K	−25%		Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings